ALIM - ALIMERA SCIENCES INC

QQQ $ 474.86 $ 2.12 (0.45 %)

DIA $ 414.87 $ 2.97 (0.72 %)

SPY $ 561.82 $ 2.92 (0.52 %)

TLT $ 100.40 $ 0.27 (0.27 %)

GLD $ 238.66 $ 2.35 (0.99 %)

Previous Close

$ 5.54

Open

$ 5.55

Bid

$ 5.53 x 100

Ask

$ 5.54 x 4,323

Day's Range

$ 5.53 - $ 5.56

52 Week Range

$ 2.61 - $ 5.65

Volume

2,678,474

Average Volume

Market Cap

301.29M

Beta (5Y Monthly)

$ 1.28

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-07-2024	06-30-2024	10-Q
2	05-14-2024	03-31-2024	10-Q
3	03-08-2024	12-31-2023	10-K
4	11-02-2023	09-30-2023	10-Q
5	08-11-2023	06-30-2023	10-Q
6	05-15-2023	03-31-2023	10-Q
7	03-31-2023	12-31-2022	10-K
8	11-14-2022	09-30-2022	10-Q
9	08-05-2022	06-30-2022	10-Q
10	05-12-2022	03-31-2022	10-Q
11	03-23-2022	12-31-2021	10-K
12	11-05-2021	09-30-2021	10-Q
13	08-16-2021	06-30-2021	10-Q
14	05-07-2021	03-31-2021	10-Q
15	03-05-2021	12-31-2020	10-K
16	11-03-2020	09-30-2020	10-Q
17	08-04-2020	06-30-2020	10-Q
18	05-06-2020	03-31-2020	10-Q
19	03-02-2020	12-31-2019	10-K
20	11-05-2019	09-30-2019	10-Q
21	08-06-2019	06-30-2019	10-Q
22	05-07-2019	03-31-2019	10-Q
23	02-25-2019	12-31-2018	10-K
24	11-09-2018	09-30-2018	10-Q
25	08-02-2018	06-30-2018	10-Q
26	05-09-2018	03-31-2018	10-Q
27	03-02-2018	12-31-2017	10-K
28	11-03-2017	09-30-2017	10-Q
29	08-10-2017	06-30-2017	10-Q
30	05-11-2017	03-31-2017	10-Q
31	03-03-2017	12-31-2016	10-K
32	11-04-2016	09-30-2016	10-Q
33	08-05-2016	06-30-2016	10-Q
34	05-06-2016	03-31-2016	10-Q
35	03-15-2016	12-31-2015	10-K
36	11-09-2015	09-30-2015	10-Q
37	08-10-2015	06-30-2015	10-Q
38	05-11-2015	03-31-2015	10-Q
39	03-13-2015	12-31-2014	10-K
40	11-14-2014	09-30-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

ANI Pharmaceuticals And Alimera Sciences A...
09/11/2024 10:56:40

crude-oil-dips-over-4-opec-cuts-global-oil-demand-outlook

Crude Oil Dips Over 4%; OPEC Cuts Global O...
09/10/2024 18:20:45

dow-dips-around-1-us-small-business-optimism-falls-in-august

Dow Dips Around 1%; US Small Business Opti...
09/10/2024 16:19:30

Alimera Sciences Takes Legal Action Agains...
09/10/2024 13:02:42

Alimera Has Filed Lawsuit in the Delaware Court of Chancery to Compel ANI to Close Merger Transaction and Honor its Contractual...

Trading Halt: Halt status updated at 8:50:...
09/09/2024 12:50:05

Alimera Sciences Q2 2024 GAAP EPS $(0.06) ...
08/06/2024 11:39:40

Alliance Global Partners Downgrades Alimer...
06/25/2024 15:17:40

Alliance Global Partners analyst James Molloy downgrades Alimera Sciences (NASDAQ:ALIM) from Buy to Neutral.

Maxim Group Downgrades Alimera Sciences to...
06/25/2024 12:47:55

Maxim Group analyst Naz Rahman downgrades Alimera Sciences (NASDAQ:ALIM) from Buy to Hold.

HC Wainwright & Co. Downgrades Alimera Sci...
06/25/2024 11:07:45

HC Wainwright & Co. analyst Yi Chen downgrades Alimera Sciences (NASDAQ:ALIM) from Buy to Neutral and maintains $6 price...

nasdaq-records-worst-session-since-april-with-nvidia-plunging-7-dow-jones-sees-modest-gains-amid-mixed-market-close

Nasdaq Records Worst Session Since April W...
06/25/2024 06:45:26

dow-jumps-300-points-alimera-sciences-shares-spike-higher

Dow Jumps 300 Points; Alimera Sciences Sha...
06/24/2024 17:06:48

generics-player-ani-pharmaceuticals-strengthens-rare-disease-segment-with-380m-alimera-sciences-deal

Generics Player ANI Pharmaceuticals Streng...
06/24/2024 15:28:28

ANI Pharmaceuticals to acquire Alimera Sciences for $5.50 per share in cash, plus a contingent value right of up to $0.50 per s...

ANI Pharma to Snap Alimera Sciences Valuin...
06/24/2024 10:55:27

ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) ("ANI" or the "Company") and Alimera Sciences, Inc. (NASDAQ:ALIM) ("...

HC Wainwright & Co. Reiterates Buy on Alim...
05/16/2024 11:08:28

HC Wainwright & Co. analyst Yi Chen reiterates Alimera Sciences (NASDAQ:ALIM) with a Buy and maintains $6 price target.

Alimera Sciences Q1 EPS $(0.12) Misses $(0...
05/14/2024 11:35:07

Alimera Sciences (NASDAQ:ALIM) reported quarterly losses of $(0.12) per share which missed the analyst consensus estimate of $(...

Alimera Announces Scientific Data Highligh...
05/07/2024 12:11:28

Alimera Sciences, Inc. (NASDAQ:ALIM) ("Alimera"), a global pharmaceutical company whose mission is to be invaluable to ...

Maxim Group Initiates Coverage On Alimera ...
03/25/2024 12:03:50

Maxim Group analyst Naz Rahman initiates coverage on Alimera Sciences (NASDAQ:ALIM) with a Buy rating and announces Price Ta...

Alimera Announces First Patient Randomized...
03/19/2024 12:05:42

HC Wainwright & Co. Maintains Buy on Alime...
03/08/2024 18:01:12

HC Wainwright & Co. analyst Yi Chen maintains Alimera Sciences (NASDAQ:ALIM) with a Buy and raises the price target from...

Alimera Sciences Expects 2024 Revenue Over...
03/07/2024 12:40:40